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Abstract
Background: Cholesterol accumulation causes pancreatic beta cell lipotoxicity and dysfunction. Cholesteryl ester
transfer protein (CETP) plays an important role in blood lipid homeostasis. However, its role in tissue lipid
metabolism remains unclear. We hypothesized that plasma CETP impact cholesterol homeostasis in the beta cells,
thus damaging their functions.
Methods: The adipose tissue-specific CETP expression transgenic (aP2-CETPTg) mice, characterized by high
CETP levels in the circulation, were used in this study. Pancreatic islet cholesterol and beta cell function were
assessed in mice. We further measured mRNA levels of the genes involved in beta cell proliferation and
differentiation, inflammation and cholesterol metabolism. TUNEL assay was applied to investigate beta cell
apoptosis in islets.
Results: The aP2-CETPTg mice exhibited glucose intolerance, lower plasma insulin concentrations but
increased insulin sensitivity compared with wild type mice. In addition, glucose-stimulated insulin secretion
from isolated pancreatic islets significantly decreased, and free cholesterol significantly increased. Moreover,
the number and size of islets from aP2-CETPTg mice were significantly decreased. Genes involved in beta cell
proliferation, such as Pdx1 and BETA2, were down-regulated; genes involved in inflammation and ER stress,
such as IL-1β, CHOP, and Xbp1 were up-regulated, in line with an increase of beta cell apoptosis.
Conclusions: Plasma CETP causes free cholesterol accumulation in islets which could contribute to beta cell
dysfunction. Thus, CETP inhibition could be a novel protective strategy for dyslipidemia related to diabetes
and obese.
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Background
The increased morbidity, mortality of type 2 diabetes
mellitus (T2DM) makes it a crucial public health con-
dition. Islet beta cell dysfunction and insulin resist-
ance are major characteristics of pathophysiology of
T2DM. Although insulin resistance occurs earlier dur-
ing disease onset, beta cell dysfunction predates long
before the occurrence of clinical hyperglycemia [1].
Many potential mechanisms for islet beta cell
dysfunction have been proposed [2], however it still
remains unclear. Lipotoxicity is regarded as one of
the possible mechanisms which contribute to beta cell
dysfunction. It has been suggested that increased free
fatty acids accumulation in beta cells could reduce in-
sulin secretion from beta cell, and induce beta cell
apoptosis [3]. Recent studies have indicated that the
accumulation of free cholesterol in beta cells may also
contribute to lipotoxicity [4] and beta cell dysfunction
[5].
Cholesteryl ester transfer protein (CETP) is a
hydrophobic plasma glycoprotein that mediates the
cholesteryl ester (CE) transfer from high density
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lipoprotein (HDL) to very low density lipoprotein
(VLDL) or low density lipoprotein (LDL) in exchange
for triglycerides, leading to lower HDL concentrations
and more small dense-LDL particles [6]. In human,
CETP is highly expressed in adipose tissue and liver,
where it can be secreted into the blood and then par-
ticipates in cholesterol metabolism [7]. We speculated
that circulating CETP may mediate cholesterol
homeostasis in islet beta cells. Some studies indicate
that CETP may have additional effects on glucose
metabolism other than lipid metabolism. A sub-study
of the Investigation of Lipid Level Management to
Understand Its Impact in Atherosclerotic Events (IL-
LUMINATE) trial reported that treatment with CETP
inhibitor (torcetrapib) improved glycemic control in
atorvastatin-treated patients with T2DM [8]. Siebel
et al. [9] found that CETP inhibitor increased postprandial
insulin and promoted ex vivo beta cell glucose-stimulated
insulin secretion, potentially via enhanced beta cell choles-
terol efflux. Most clinical studies have shown that CETP
mass was increased in patients with T2DM and obesity
[10]. CETP activity was positively correlated with fasting
blood glucose and HbA1c while negatively correlated with
HDL-C in T2DM [11]. Few studies also reported diabetes
may suppress hepatic CETP in obese [12, 13]. Our previ-
ous study showed that glucose uptake and intracellular
cholesterol were increased when 3T3-L1 adipocyte was
transfected with CETP [14]. All these studies indicated
that CETP might play a role in glucose metabolism.
We previously generated adipose tissue-specific
CETP expression transgenic (aP2-CETPTg) mice and
demonstrated that this model have the following char-
acteristics: 1) high circulating CETP secreted by adi-
pose tissue; 2) elevated LDL and declined HDL levels
compared with WT mice; 3) very low CETP expres-
sion in other tissues (including skeletal muscle, liver,
lung, kidney, heart, and brain) [15]. Natural flanking
region (NFR)-CETPTg mice is another CETP trans-
genic mouse model with human like CETP concentra-
tion in the circulation and tissue distributions (liver,
spleen, small intestine, kidney, and adipose tissue)
[16]. Recently, Raposo et al. reported physiological
levels of CETP (~2 μg/ml) did not affect glucose
homeostasis and insulin secretion [17]. Interestingly,
we previously found that over-expressed CETP might
modulate glucose metabolism and insulin action in
addition to its effects on lipoprotein metabolism in
3T3-L1 adipocytes [14]. In order to investigate
whether circulating CETP (other than local CETP ex-
pression) and elevated CETP activity play roles in
regulation of glucose metabolism and beta cell lipid
accumulation, we used aP2-CETPTg mouse to explore
the effects of CETP on mouse pancreatic beta cell
lipid composition and beta cell function.
Methods
Animals
The NFR-CETPTg and aP2-CETPTg mice have C57BL/
6J background [15]. Transgenic mice and non-transgenic
littermates were fed standard rodent chow diet, housed
in cages in a pathogen-free facility, and maintained on a
12 h light/12 h dark cycle. All experiments were per-
formed on 10~16 week-old male mice. All animal exper-
iments were conducted in accord with accepted
standards of humane animal care, as outlined in the Eth-
ical Guidelines, and were approved by the Research Ani-
mal Care Committee of Nanjing Medical University
(IACUC-14030136).
CETP activity measurement
Mouse plasma CETP activity was measured by a fluores-
cence method as previously described [15]. Briefly,
NBD-CE works as the donor, and ultracentrifugation
separated human VLDL/LDL works as the acceptor. Re-
actions were performed in a 100 μl reaction mixture
containing 3 μl plasma sample. Finally, fluorescence
were measured by fluorescence microplate (SynergyMx,
BioTek, United States) under 460 nm excitation wave
and 530 nm emission wave. Plasma CETP activity was
presented as detected fluorescence value (arbitrary
units)/3 μl plasma).
Glucose and insulin tolerance test
Intraperitoneal glucose tolerance test (IPGTT) was per-
formed on 16 h-fasted mice injected with D-glucose at
1 g/kg body weight. Blood glucose levels were measured
at 0, 15, 30, 60 and 120 min after glucose injection.
Plasma insulin during IPGTT was measured by Mouse
Insulin ELISA kit (Millipore-linco, Billerica, MA, USA).
Intraperitoneal insulin tolerance test (IPITT) was per-
formed on 5 h-fasted mice injected with recombinant
human insulin (Humulin, Eli Lilly and company, China)
at 0.75 mU/kg body weight. Blood glucose levels were
measured at 0, 15, 30, 60 and 120 min after insulin
injection.
Isolation of pancreatic islets
Primary mouse islets were isolated by collagenase V
(Sigma-Aldrich Chemie, Steinheim, Germany) digestion
and filtration as previously described [18]. Islets used for
glucose-stimulated insulin secretion measurement were
cultured in RPMI-1640 (Gibco, California, USA) supple-
mented with 10 % FCS (Gibco, California, USA), 100 U/
ml penicillin and 100 μg/ml streptomycin. Islets used for
cholesterol measurement and real-time PCR were washed
with PBS and frozen down immediately after isolation.
Isolated islets number counting was conducted by two
persons in a double-blinded fashion, referring to the
method used by Ishikawa [19].
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Glucose-stimulated insulin secretion assay
After overnight culture, islets were washed and used
for glucose-stimulated insulin secretion (GSIS). Islets
(eight similar-sized islets per well and eight wells per
group) were firstly pre-incubated in Krebs-Ringer bi-
carbonate HEPES buffer supplemented with 0.2 %
BSA for 1 h at 37 °C and 5 % CO2, then incubated
with KRB/HEPES buffer supplemented with 0.2 %
BSA containing 3.3 or 16.7 mmol/l glucose for 1 h
[18]. After then, islets were incubated with acid-
ethanol (1.5 % HCl in 70 % Ethanol) overnight for in-
sulin content measurement. The supernatants were
collected after each treatment. Insulin levels were
measured by the radioimmunoassay kit (BNIBT,
Beijing, China). Insulin secretion ability is calculated
by the relative secreted insulin to insulin content.
Plasma lipid measurement
Overnight fasting plasma were collected for plasma
lipid measurement. The total cholesterol (TC), free
cholesterol (FC) were assayed by enzymatic methods
(Applygen Technologies Inc. Beijing, China), accord-
ing to the instructions provided by the manufacturers.
CE concentration is calculated by TC minus FC.
Islet lipid determination
Twenty similar-sized islets were washed five times
with PBS and then cellular lipids were extracted by
hexane: isopropyl alcohol (2:1 v/v) as described [20],
using β-sitosterol (5 μg/ml) as an internal standard.
Samples were split into two equal fractions to meas-
ure FC and TC separately. For TC measurement, CE
was firstly transformed into free cholesterol. Finally,
CE content is calculated by TC minus FC. To
hydrolyze cellular cholesteryl esters prior to gas chro-
matography, 50 % KOH (200 μl) and methanol (3 ml)
were added to dried aliquots and heated to 80 °C for
1 h in argon-capped tubes. After cooling, 3 ml H2O
and 5 ml HPLC grade hexane were added. Samples
were centrifuged at 1000 rpm for 5 min and super-
natant containing cholesterol was removed and dried
under nitrogen. Cholesterol mass was measured by
injection of 1 μl aliquots into a 5890 Series II gas
chromatograph with a Detector (FID DETECTOR)
using a 15 m × 0.53 mm × 1.5 μm cross-linked HP-5
Trace Analysis (5 % Ph Me Siloxane) column. Gas
chromatography was performed at an isothermal
260 °C, injection port temperature of 300 °C, and de-
tector temperature of 300 °C with nitrogen carrier
flow rate of 30 ml/min. Calibration was achieved by
injection of a standard solution of cholesterol
(100 μg/ml).
RNA extraction, reverse transcription and gene
expression
Total RNA from isolated islets were extracted using
the RNAiso Plus (Takara, Dalian, China) and reverse-
transcribed into cDNA using the Prime Script RT re-
agent kit (Takara, Dalian, China). Data for triplex
real-time PCR assay were collected with an AB 7500
Real time PCR system (Applied Biosystems, Inc.
United States). Reactions were performed with SYBR
Green PCR Master Mix (Takara, Dalian, China) under
following thermal cycling conditions: 2 min at 50 °C,
10 min at 95 °C, followed by 40 cycles of 95 °C for
15 s and 60 °C for 1 min. Conventional PCR reac-
tions were performed in a 20 μl reaction mixture
containing 0.5 μmol/L primers and 12.5 mg/L cDNA.
Relative gene expression data were analyzed in the 2-
ΔΔCT method, and the results were expressed as the
expression fold over the control group. In exception,
since there is no CETP mRNA expression in WT
mice, the relative CETP mRNA of adipose tissue from
aP2-CETPTg mice and NFR-CETPTg mice and of is-
lets from NFR-CETPTg mice were expressed as 2^-







Ki-67 reverse, 5′-GCTCGCCTTGATGGTTCCT- 3′.
Pdx1 forward, 5′-GATGAAATCCACCAAAGCTC
A- 3′;





IL-1β forward, 5′- TGCAGAGTTCCCCAACTGGTA-
CATC- 3′;
IL-1β reverse, 5′- GTGCTGCCTAATGTCCCCTT-
GAATC- 3.
TNF-α forward, 5′- CCCTCACACTCAGATCATC
TTCT- 3′;
TNF-α reverse, 5′- GCTACGACGTGGGCTACAG- 3′.
IL-6 forward, 5′- CCAAGAGGTGAGTGCTTCCC- 3′;
IL-6 reverse, 5′- CTGTTGTTCAGACTCTCTCCCT- 3′.
IL-10 forward, 5′- GCTCTTACTGACTGGCATGA
G- 3′;





Atf6 forward, 5′- GACTCACCCATCCGAGTTGTG- 3′;
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Atf6 reverse, 5′- CTCCCAGTCTTCATCTGGTCC- 3′.
Xbp1 forward, 5′- AGCAGCAAGTGGTGGATTTG- 3′;
Xbp1 reverse, 5′- GAGTTTTCTCCCGTAAAAGCTGA-
3′.
Ldlr forward, 5′-CTGTTCCCA CCTCTGTTTAC- 3′;
Ldlr reverse, 5′- AGTGAG ATACGGCGA ATA GA- 3′.
HMGCS forward, 5′-TGG GAC CAA CCT TCT ACC
TC- 3′;







Pancreata were isolated, fixed with 10 % buffered for-
malin, embedded in paraffin, sectioned and stained
with hematoxylin and eosin for histological analysis.
Pancreatic sections were scanned by Zeiss microscope
at ×200 magnifications and islet size was analyzed
with AxioVision software. For analysis of pancreatic
islet apoptosis, double staining of in situ cell death
detection fluorescence and insulin fluorescent immu-
nohistochemistry were performed. The following pri-
mary antibodies were used: Rabbit anti-insulin
polyclonal antibody, 1:50 (Proteintech Group, Inc.
Chicago, USA); Secondary antibodies DyLight594
rabbit anti-goat IgG[H+L], 1:300 (MultiSciences Bio-
tech, Hangzhou, China). The beta cell apoptosis was
assessed by transferase-mediated dUTP nick-end la-
beling (TUNEL) assay (keyGEN, Nanjing, China) ac-
cording to the manufacturer’s protocol. For the
determination of the overall rate of apoptosis, each
section stained for insulin, TUNEL, and DAPI were
imaged at 400 magnification (40 × objective), and the
total number of TUNEL-positive cells per field were
quantified. To determine the frequency of beta cell
apoptosis, the number of cells positive for TUNEL
was quantified in each islet and expressed as percent-
age of the total number of beta cells (n = ~4000). Beta
cells were counted in 16 week old of age male mice
per genotype (n = 4–5).
Statistical analysis and calculation
Data are expressed as means ± SD. Differences between
groups were calculated by Student’s t test. Data were an-
alyzed using GraphPad Prism Software version 5.0, with
significance defined as p < 0.05 (two-tailed). HOMA-IR
is calculated by fasting plasma glucose (mmol/L) × fast-
ing insulin (mIU/L)/22.5; HOMA-β is calculated by 20 ×
fasting insulin (mIU/L)/(fasting plasma glucose (mmol/
L) − 3.5) (%).
Results
Characteristics of CETP transgenic mice
Wild-type (WT), NFR-CETPTg and aP2-CETPTg mice
did not show differences in body weight in the age of 8
to 20 week (Fig. 1). The CETP mRNA in the adipose tis-
sue was significantly higher in aP2-CETPTg mice than
in NFR-CETPTg mice, but not expressed in WT litter-
mates as expected (Fig. 2a). In consistent with the real-
time PCR results, no CETP activity was detected in WT
mice whereas high plasma CETP levels in aP2-CETPTg
mice (OD value = 12,600 ± 784/μl), which is up to 2.3
folds of that in human plasma (OD value = 5570 ± 171/
μl). Moreover, there is no detectable CETP mRNA ex-
pression in the isolated islets from WT and aP2-CETPTg
mice, while a certain CETP expression in the islets from
NFR-CETPTg mice (Fig. 2b).
aP2-CETPTg mice exhibit impaired glucose tolerance and
insulin secretion
To study the effects of CETP on systemic glucose me-
tabolism and insulin secretion in NFR-CETPTg and aP2-
CETPTg mice, we conducted IPGTT, IPITT in vivo. A
glucose challenge (1 g/kg) revealed an impaired glucose
tolerance in aP2-CETPTg mice (p < 0.05), compared with
WT mice, while a glucose intolerance tendency in NFR-
CETPTg mice (Fig. 3a). Interestingly, we also found that
NFR-CETPTg and aP2-CETPTg mice had an increased
sensitivity to insulin compared with WT mice (Fig. 3b).
The homeostasis model assessment of insulin resistance
(HOMA-IR) of NFR-CETPTg and aP2-CETPTg mice
were lower compared with WT mice (4.24 ± 1.19, 2.47 ±
0.54, 6.14 ± 3.14, respectively, p < 0.05), which also sug-
gested that insulin sensitivity of aP2-CETPTg mice were
higher. Besides, both NFR-CETPTg and aP2-CETPTg
mice had significantly decreased plasma fasting insulin
than WT mice (p < 0.001) (Fig. 3c). We further
Fig. 1 Body weight of NFR-CETPTg, aP2-CETPTg and WT mice. Body
weight records at 8, 12, 16 and 20 week-old mice. No significant
difference between NFR-CETPTg, aP2-CETPTg and WT mice (n = 6
per group). Values are expressed as mean ± SD
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measured insulin levels after glucose overload, and we
found that aP2-CETPTg mice had less insulin secretion
than WT mice, especially at 0 and 60 min (p < 0.05)
(Fig. 3d). Homeostasis model assessment of beta cell
function index (HOMA-β) of NFR-CETPTg and aP2-
CETPTg mice were lower compared with WT mice
(48.7 ± 26.2, 56.9 ± 24.0, 96.6 ± 31.6, repectively, p <
0.05), which indicated beta cell dysfunction in aP2-
CETPTg mice. Furthermore, we found that islets from
aP2-CETPTg mice had a significant reduction in
glucose-stimulated insulin secretion in vitro compared
with that from WT mice (p < 0.05) (Fig. 3e). Collectively,
both NFR-CETPTg and aP2-CETPTg mice have im-
paired glucose tolerance and insulin secretion, but in-
creased insulin sensitivity. Moreover, we also found that
there was a CETP dose-dependent effect on glucose
tolerance.
aP2-CETPTg mice have fewer and smaller islets
Islets from aP2-CETPTg mice exhibited less islet num-
ber (138 ± 14 vs.166 ± 10, p < 0.05) (Fig. 4d) and smaller
size (6850 ± 6940 vs. 9780 ± 10,100 μm2, p < 0.05) com-
pared with WT mice, which was clearly reflected by fre-
quency distribution and mean area quantification on the
pancreatic H-E staining sections (10 sections from two
separate levels per mouse, 9–10 mice per group)
(Fig. 4a–c).
aP2-CETPTg mice have higher apoptosis rate in beta cell
We next sought to determine whether decreased insulin
secretion and smaller sized islets in aP2-CETPTg mice
result from increased apoptosis of beta cells? Immuno-
fluorescence stating of pancreas sections were conducted
to quantify apoptosis rate of beta cells in aP2-CETP and
WT mice. Results showed that the frequency of
TUNEL-positive beta cell significantly increased in aP2-
CETPTg mice (Fig. 5), indicating that circulating CETP
could induce beta cell apoptosis. To further explain the
reduction of islet mass, we next measured general prolif-
eration marker Ki-67 and beta cell specific transcription
factors, pancreatic and duodenal homeobox 1 (Pdx1)
and BETA2. Ki-67 mRNA level was increased but the
latter two both were suppressed in aP2-CETPTg mice
(Fig. 6).
Circulating CETP promotes free cholesterol accumulation
in the islets
To investigate the effect of CETP on islet lipid content,
we utilized gas chromatograph to determine the lipid
profile in the islets and found that FC (15.6 ± 3.60 vs.
10.3 ± 1.62 mmol/mg protein, p < 0.05), FC/CE ratio
(2.44 ± 0.640 vs. 1.20 ± 0.430, p < 0.05) but not total chol-
esterol (22.0 ± 3.83 vs. 19.9 ± 2.13 mmol/mg protein, p =
0.216) were significantly increased in the transgenic mice
islets compared with controls (Fig. 7a). In addition,
plasma TC and CE were significantly decreased in aP2-
CETPTg mice than WT mice (Fig. 7b), no difference
was observed in FC (Fig. 7b) but FC/CE ratio induced
(Fig. 7c). ACAT1 converts FC to CE, playing an import-
ant role in cellular cholesterol homeostasis, but ACAT1
mRNA in islets did not differ between the two groups
(Fig. 7b). We further found that mRNA levels of choles-
terol synthesis and uptake related genes, 3-hydroxy-3-
methylglutaryl-CoA synthase (HMGCS), sterol regula-
tory element-binding protein-2 (SREBP-2), and LDL re-
ceptor (LDLR) were all significantly reduced (71, 41,
71 %, respectively) (Fig. 8).
The effect of circulating CETP on the expression of genes
participated in islet inflammation and ER stress
Islet inflammation is emerging as an important factor
that participates in the development of T2DM [21].
Thus, we sought to examine mRNA levels of IL-1β,
TNF-α and IL-6, these representative pro-inflammatory
cytokines that play key roles in modulating islet cytokine
Fig. 2 CETP mRNA expression in adipose tissue and islets. Real-time
PCR CETP mRNA analysis in mouse adipose tissue (a) and isolated islets
(b). In aP2-CETPTg mice, CETP is predominantly expressed in adipose
tissue but not detectable in islets, while a regular CETP expression in
NFR-CETPTg mice. No CETP gene expression is noted in their controls.
n = 6 per group. Values are expressed as mean ± SD
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Fig. 3 (See legend on next page.)
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release and impairs islet function [21]. The results indi-
cated that IL-1β mRNA was significantly increased in is-
lets of aP2-CETPTg mice, but without differences in
TNF-α, IL-6 or IL-10 mRNA expression (Fig. 9a).
Free cholesterol accumulation in macrophages leads to
CHOP-induced ER stress [22]. To investigate whether
unfolded protein response is enhanced in the islets from
aP2-CETPTg mice, we measured the mRNA expression
of CHOP, X-box binding protein 1 (Xbp1) and activating
transcription factor 6 (Atf6). Our data showed that the
mRNA levels of CHOP and Xbp1 were also increased in
aP2-CETPTg mouse islets (Fig. 9b), suggesting that cir-
culating CETP could be cytotoxic to beta cells. Atf6 did
not differ between the islets from aP2-CETPTg and WT
mice (Fig. 9b).
Discussion
In this study, we demonstrated for the first time that cir-
culating CETP, 1) exacerbate glucose intolerance, lower
plasma insulin concentrations but increase insulin sensi-
tivity; 2) increase free cholesterol accumulation in the is-
lets; 3) reduce the expression of the genes which
participate in beta cell proliferation and differentiation,
resulting in fewer and smaller islet number and size; 4)
induced the expression of the genes which are involved
in inflammation, ER stress, and apoptosis; and 5) finally
and most importantly, circulating CETP decreased insu-
lin secretion from islet beta cells.
It is well known that insulin resistance and insulin de-
ficiency are main factors of glucose intolerance. In our
aP2-CETPTg mice, insulin sensitivity is increased, com-
pared with WT mice. This could be due to two reasons,
1) adipocyte size becomes smaller [23], and 2) skeletal
muscle takes up more glucose. Although aP2-CETPTg
mice had increased insulin sensitivity, they displayed
glucose intolerance and this could be due to beta cell
dysfunction.
Circulating CETP influences insulin sensitivity and in-
sulin secretion in a dose-dependent fashion. Recently,
Raposo et al. [17] reported that CETP expression does
not affect glucose homeostasis and insulin secretion.
However, our GTT results clearly indicated that there is
a CETP dose-dependent effect on mice glucose tolerance
impairment and fasting insulin secretion dysfunction.
Therefore, the inconsistent results between Raposo et
al’s and ours’ could be mainly due to the different CETP
levels in the blood. Raposo et al. utilized a heterozygous
CETP transgenic (NFR-CETP-Tg) mice model which is
identical to our NFR-CETP-Tg mice, presenting human
like plasma levels of CETP (~2 ug/ml). However, our
aP2-CETPTg mice have significantly higher levels of
CETP in circulation. Therefore, elevated CETP mass and
activity in T2DM patients may bring additional damage
to insulin secretion.
What is the mechanism for beta cell dysfunction in
aP2-CETPTg mice? We hypothesized that free choles-
terol accumulation in aP2-CETPTg mice islet induce
beta cell dysfunction. It is known that high cholesterol
levels in islets interfere with glucose metabolism by inhi-
biting glucokinase activity, the critical glucose-sensing
component of the beta cell, and reducing the effective-
ness of the insulin secretory apparatus [4, 24]. ATP-
binding cassette transporter A1 (ABCA1) is a cellular
cholesterol transporter which participates in cholesterol
efflux, mice lacking beta cell ABCA1 exhibited impaired
glucose tolerance and decreased insulin secretion due to
abnormalities of cholesterol homeostasis in isolated is-
lets [25]. SREBP-2 is another member of the membrane-
bound transcription factor SREBP family, and plays a
crucial role in the regulation of cholesterol metabolism
[19]. Expression of nuclear human SREBP-2 in beta cells
resulted in severe diabetes due to defects in glucose- and
potassium-stimulated insulin secretion. Cholesterol is a
well-known component of both secretory granules and
plasma membranes, and cholesterol-rich microdomains
in the plasma membrane are thought to be essential for
normal cell function, including exocytosis [26, 27]. The
cholesterol-rich lipid rafts in beta cell membranes con-
tain calcium channels and the proteins that constitute
the secretory apparatus which consists of soluble N-
ethylmaleimide-sensitive factor (NST) attachment
protein receptor (SNARE), soluble NST attachment
(See figure on previous page.)
Fig. 3 Impaired glucose tolerance and decreased insulin secretion in aP2-CETPTg mice in vivo and in vitro. a IPGTT was performed in 10–12
week-old mice by intraperitoneal injecting D-glucose (1 g/kg body weight). Blood glucose levels were measured at 0, 15, 30, 60 and 120 min
during IPGTT. n = 6 per group. Area under curve is calculated and showed (right). The aP2-CETPTg mice have impaired glucose tolerance than WT
mice. b IPITT was performed in 10–12 week-old mice by intraperitoneal injecting insulin (0.75 IU/kg body weight). Blood glucose were recorded
at 0, 15, 30, 60 and 120 min during IPITT. n = 6 per group. Area under curve is calculated and showed (right). The insulin sensitivity is increased in
the NFR-CETPTg and aP2-CETPTg mice. c Plasma fasting insulin levels in NFR-CETPTg, aP2-CETPTg and WT mice. CETP transgenic mice exhibited
decreased fasting insulin secretion than WT mice. n = 5 per group. d Plasma insulin levels were measured at 0, 15, 30 and 60 min during IPGTT in
WT and aP2-CETPTg mice. After glucose challenge, aP2-CETPTg mice secreted less insulin than WT mice. n = 6 per group. e Insulin secretion ability
was measured from isolated islets by glucose-stimulated insulin secretion. Eight islets per well, eight wells per group. Insulin release in response
to 16.7 mmol/l glucose was significantly impaired in aP2-CETPTg mice compared with WT mice. Values are expressed as mean ± SD. *p < 0.05
compared with control group, **p < 0.01 compared with control group. IPGTT intraperitoneal glucose tolerance test, IPITT intraperitoneal insulin
tolerance test













Fig. 4 (See legend on next page.)
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protein-25 (SNAP-25), and synaptobrevin. All of these
proteins participate in insulin secretion. The accumula-
tion of cholesterol in beta cell interferes with the effect-
iveness of the insulin secretory apparatus then decrease
insulin secretion. Conversely, lowering beta cell choles-
terol levels with methyl-β-cyclodextrin [4, 28], which de-
pletes membrane cholesterol, increases insulin secretion.
Our results indicated that FC/CE of islets was increased
in the islets from aP2-CETPTg mice when compared
with WT mice. Moreover, the free cholesterol accumula-
tion is not directly result from ACAT mRNA level
changes. Enrichment of FC changes beta cell membrane
lipid composition and this could lead to less efficiency in
insulin secretion through exocytosis.
Our study showed that the size of islets from aP2-
CETPTg mice were significantly reduced, which could be
another reason for the decrease of insulin secretion. These
morphologic variations of islets in aP2-CETPTg mice
might be a consequence of cholesterol accumulation in
the beta cells. Studies in macrophages demonstrated that
free cholesterol induces apoptosis by causing stiffening of
the ER membrane, with subsequent induction of the un-
folded protein response [29]. Our data also showed that
beta cell apoptosis was increased, in line with higher ex-
pression of ER stress markers, including CHOP and Xbp1.
Cholesterol accumulation can decrease expression of the
beta cell specific proliferation and differentiation genes,
Pdx1 and BETA2, which may be another reason for the
decrease of beta cell number and size. Interestingly, Ki-67
mRNA expression was upregulated in aP2-CETPTg mice,
which may be a feedback regulation of increased beta cell
apoptosis. Islet inflammation has been reported in T2DM,
and individuals with elevated serum levels of certain pro-
inflammatory cytokines show increased risks for
developing T2DM [30]. IL-1β is well established as a pro-
inflammatory cytokine involved with the demise of the
beta cell [31]. Our results showed that IL-1β mRNA was
significantly increased in islets of aP2-CETPTg mice.
The question arises as to how CETP might promote
free cholesterol accumulation in pancreatic beta cells.
CETP has been reported to exchange lipids between cell
membranes and between cell membranes and lipopro-
teins. For example, CETP can mediate efflux of choles-
teryl ester from biological membranes to lipoproteins
[32, 33]. CETP can also facilitate HDL-cholesterol select-
ive uptake by adipocytes [34]. It is conceivable that
CETP could also facilitate cholesteryl ester efflux out of
the plasma membrane of cell, thus causing free choles-
terol accumulation in the cells. It has been suggested
that CETP could enhance the exchange of lipids during
the formation of a ternary collision complex consisting
of donor and acceptor lipoproteins, bridged by CETP
[35]. By analogy, CETP might bind the HDL to the
plasma membrane of cell, and increase the collisions be-
tween the membrane and the lipoprotein, allowing lipids
to be exchanged in the process. We speculate that circu-
lating CETP could transfer cholesteryl ester but not free
cholesterol out of the beta cell to lipoproteins in the
(See figure on previous page.)
Fig. 4 Morphology, number and area distribution of islets from aP2-CETPTg mice. a Representative pancreas sections of aP2-CETPTg mice and
WT mice were stained with hematoxylin and eosin for histological analysis. Original magnification, ×50 (left panels); ×100 (right panels). Islets are
marked with asterisk and arrow. b The area distribution of islets on H-E staining pancreas sections. (aP2-CETPTg, n = 9; WT, n = 10; 10 sections at
two separate levels per mouse pancreas). Islets from aP2-CETPTg mice were smaller in size than that from WT mice. c Area quantification of islets
on pancreas sections displayed significant decreased area in aP2-CETPTg mice. d Pancreatic islets were isolated from aP2-CETPTg mice and WT
mice (n = 6 per group) and double-blinded counted by two persons. Islets isolated from aP2-CETPTg mice were fewer than that from WT mice.
Values are expressed as mean ± SD. **p < 0.01, compared with control group
Fig. 5 Increased beta cell apoptosis in aP2-CETPTg mice compared with WT mice by TUNEL. Representative TUNEL-positive beta cells were
marked with white arrows (Left). The number of cells positive for TUNEL was quantified in every single islet and expressed as percentage of the
total number of beta cells (n = ~4000) (Right). Beta cells were counted in immunofluorescence staining pancreas section form 16 week-old male
mice (n = 5 per group). Values are expressed as mean ± SD. **p < 0.01, compared with control group
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circulation, resulting in elevation of FC/CE ratio in the
islets, and the precise mechanism needs further study.
Conclusions
In summary, our data show that circulating CETP
have an impact on beta cell cholesterol homeostasis
by accumulation of free cholesterol, thus reducing
beta cell insulin secretion. These data provide further
evidence to the concept that regulation of beta cell
cholesterol homeostasis is essential for normal islet
function. CETP inhibition could be a potential prom-
ising approach to improve beta cell function in
T2DM by decreasing islet cholesterol accumulation
and inflammation.
Fig. 6 Expression of proliferation and differentiation related
genes in isolated islets from aP2-CETPTg mice. Ki-67 mRNA level
was significantly upregulated in islets from aP2-CETPTg mice. The
mRNA expression of Pdx1 and BETA2 were decreased compared
with WT mice. Values are expressed as mean ± SD. *p < 0.05, **p
< 0.01, and *** p < 0.001 compared with control group. n = 5 per
group. Pdx1 pancreatic and duodenal homeobox 1
Fig. 7 Lipid profile in plasma and islets from ap2-CETPTg mice. a Total cholesterol, free cholesterol, and cholesteryl ester of islets isolated from aP2-
CETPTg mice and WT mice (20 islets per mice, 5 mice per group) were extracted and measured as described in the Methods. b Plasma cholesterol
profile in aP2-CETPTg and WT mice (n = 10 per group). c The FC/CE ratio in plasma and islets. d ACAT1 mRNA expression does not differ in the two
groups. Values are expressed as mean ± SD. *p < 0.05 and **p < 0.01, ***p < 0.001, compared with control group
Fig. 8 Expression of cholesterol synthesis and uptake related genes
in isolated islets from aP2-CETPTg mice. Relative mRNA levels of
HMGCS, Srebp2 and Ldlr in isolated islets. n = 5 per group. Values
are expressed as mean ± SD. *p < 0.05 and **p < 0.01, compared with
control group. HMGCS 3-hydroxy-3-methylglutaryl-CoA synthase,
Srebp2 sterol regulatory element-binding protein 2, Ldlr LDL receptor
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ABCA1: ATP-binding cassette transporter A1; Atf6: activating transcription
factor 6; aP2-CETPTg: adipose tissue-specific CETP expression transgenic;
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protein 1.
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